Barros, A. and V. Hirakata (2003). "Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio." BMC Med Res Methodol 3: 21.              

 

 

Berkley, S. (2003). "Thorny issues in the ethics of AIDS vaccine trials." Lancet 362(9388): 992.            

 

 

Binley, J. M., C. S. Cayanan, C. Wiley, N. Schulke, W. C. Olson and D. R. Burton (2003). "Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions." J Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions Virol 77(10): 5678-5684.          

 

 

Boaz, M. J., A. Waters, S. Murad, P. J. Easterbrook, E. D'Sousa, C. van Wheeley and A. Vyakarnam (2003). "CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects." Clin Exp Immunol 134(3): 454-463.          

 

 

Cavacini, L., M. Duval, L. Song, R. Sangster, S. H. Xiang, J. Sodroski and M. Posner (2003). "Conformational changes in env oligomer induced by an antibody dependent on the V3 loop base." AIDS 17(5): 685-689.           

 

 

Choe, H., W. Li, P. L. Wright, N. Vasilieva, M. Venturi, C. C. Huang, C. Grundner, T. Dorfman, M. B. Zwick, L. Wang, E. S. Rosenberg, P. D. Kwong, D. R. Burton, J. E. Robinson, J. G. Sodroski and M. Farzan (2003). "Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120." Cell 114(2): 161-170.             

 

 

Excler, J. (2003). "HIV vaccine development in Asia." J Health Management 5: 327-341.            

 

 

Eyeson, J., D. King, M. J. Boaz, E. Sefia, S. Tomkins, A. Waters, P. J. Easterbrook and A. Vyakarnam (2003). "Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects." AIDS 17(16): 2299-2311.          

 

   

Fiebig, E. W., D. J. Wright, B. D. Rawal, P. E. Garrett, R. T. Schumacher, L. Peddada, C. Heldebrant, R. Smith, A. Conrad, S. H. Kleinman and M. P. Busch (2003). "Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection." AIDS 17(13): 1871-1879.      

 

    

Girard MP, Mastro TD and Koff WC (2003). Human immunodeficiency virus. Vaccines. S. Plotkin and W. Orenstein. Philadelphia Saunders Press: 1219-1259.     

 

          

Hanke, T. (2003). "Development of prophylactic AIDS vaccines: the current state of affairs." Curr Opin Mol Ther 5(1): 25-32.     

 

       

Hanke, T., C. Barnfield, E. G. Wee, L. Agren, R. V. Samuel, N. Larke and P. Liljestrom (2003). "Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine." J Gen Virol 84(Pt 2): 361-368.            

 

 

Johnson, W. E., H. Sanford, L. Schwall, D. R. Burton, P. W. Parren, J. E. Robinson and R. C. Desrosiers (2003). "Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities." J Virol 77(18): 9993-10003.           

 

 

Karlsson, G. B. and P. Liljestrom (2003). "Live viral vectors: Semliki Forest virus." Methods Mol Med 87: 69-82.       

 

     

Klausner, R. D., A. S. Fauci, L. Corey, G. J. Nabel, H. Gayle, S. Berkley, B. F. Haynes, D. Baltimore, C. Collins, R. G. Douglas, J. Esparza, D. P. Francis, N. K. Ganguly, J. L. Gerberding, M. I. Johnston, M. D. Kazatchkine, A. J. McMichael, M. W. Makgoba, G. Pantaleo, P. Piot, Y. Shao, E. Tramont, H. Varmus and J. N. Wasserheit (2003). "Medicine. The need for a global HIV vaccine enterprise." Science 300(5628): 2036-2039.            

 

 

Koch, M., M. Pancera, P. D. Kwong, P. Kolchinsky, C. Grundner, L. Wang, W. A. Hendrickson, J. Sodroski and R. Wyatt (2003). "Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition." Virology 313(2): 387-400.            

 

 

LaBonte, J. A., N. Madani and J. Sodroski (2003). "Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression." J Virol 77(12): 6645-6659.            

 

 

Labrijn, A. F., P. Poignard, A. Raja, M. B. Zwick, K. Delgado, M. Franti, J. Binley, V. Vivona, C. Grundner, C. C. Huang, M. Venturi, C. J. Petropoulos, T. Wrin, D. S. Dimitrov, J. Robinson, P. D. Kwong, R. T. Wyatt, J. Sodroski and D. R. Burton (2003). "Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1." J Virol 77(19): 10557-10565.              

 

 

Moore, J. P. and R. W. Doms (2003). "The entry of entry inhibitors: a fusion of science and medicine." Proc Natl Acad Sci U S A 100(19): 10598-10602.       

 

    

Nayyar A, Excler JL and Chataway M (2003). "Does India need an AIDS Vaccine?" Health for the Millions February-May: 66-73.          

 

 

O'Connor, D. H., B. R. Mothe, J. T. Weinfurter, S. Fuenger, W. M. Rehrauer, P. Jing, R. R. Rudersdorf, M. E. Liebl, K. Krebs, J. Vasquez, E. Dodds, J. Loffredo, S. Martin, A. B. McDermott, T. M. Allen, C. Wang, G. G. Doxiadis, D. C. Montefiori, A. Hughes, D. R. Burton, D. B. Allison, S. M. Wolinsky, R. Bontrop, L. J. Picker and D. I. Watkins (2003). "Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses." J Virol 77(16): 9029-9040.              

 

 

Otto, C., B. A. Puffer, S. Pohlmann, R. W. Doms and F. Kirchhoff (2003). "Mutations in the C3 region of human and simian immunodeficiency virus envelope have differential effects on viral infectivity, replication, and CD4-dependency." Virology 315(2): 292-302.            

 

 

Pantophlet, R., I. A. Wilson and D. R. Burton (2003). "Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design." J Virol 77(10): 5889-5901.               

Pierson, T. C. and R. W. Doms (2003). "HIV-1 entry and its inhibition." Curr Top Microbiol Immunol 281: 1-27.     

 

         

Santoli, J. M., G. Peter, A. M. Arvin, J. P. Davis, M. D. Decker, P. Fast, F. A. Guerra, C. M. Helms, A. R. Hinman, R. Katz, J. O. Klein, M. B. Koslap-Petraco, P. R. Paradiso, W. Schaffner, P. N. Whitley-Williams, D. E. Williamson, B. Gellin and C. National Vaccine Advisory (2003). "Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee." JAMA 290(23): 3122-3128.           

 

 

Schnepp, B. C., K. R. Clark, D. L. Klemanski, C. A. Pacak and P. R. Johnson (2003). "Genetic fate of recombinant adeno-associated virus vector genomes in muscle." J Virol 77(6): 3495-3504.              

 

 

Si, Z., N. Phan, E. Kiprilov and J. Sodroski (2003). "Effects of HIV type 1 envelope glycoprotein proteolytic processing on antigenicity." AIDS Res Hum Retroviruses 19(3): 217-226.

 

 

Veazey, R. S., P. J. Klasse, T. J. Ketas, J. D. Reeves, M. Piatak, Jr., K. Kunstman, S. E. Kuhmann, P. A. Marx, J. D. Lifson, J. Dufour, M. Mefford, I. Pandrea, S. M. Wolinsky, R. W. Doms, J. A. DeMartino, S. J. Siciliano, K. Lyons, M. S. Springer and J. P. Moore (2003). "Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection." J Exp Med 198(10): 1551-1562.             

 

 

Vodros, D., R. Thorstensson, R. W. Doms, E. M. Fenyo and J. D. Reeves (2003). "Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques." Virology 316(1): 17-28.           

 

 

Xiang, S. H., L. Wang, M. Abreu, C. C. Huang, P. D. Kwong, E. Rosenberg, J. E. Robinson and J. Sodroski (2003). "Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains." Virology 315(1): 124-134.

 

             

Yang, X., E. Mahony, G. H. Holm, A. Kassa and J. Sodroski (2003). "Role of the gp120 inner domain beta-sandwich in the interaction between the human immunodeficiency virus envelope glycoprotein subunits." Virology 313(1): 117-125.